Trials / Completed
CompletedNCT03818347
Hydrogen Gas for Cancer Rehabilitation
Hydrogen Gas Immunotherapy Promotes the Rehabilitation and Prognosis of Cancer Patients After Standard Treatments
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fuda Cancer Hospital, Guangzhou · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is the efficacy of hydrogen gas immunotherapy to rehabilitation and prognosis of cancer patients.
Detailed description
By enrolling patients of multiple kinds of cancer adapted to enrolled criteria, this study will document for the first time the short and long term efficacy of hydrogen gas.The evaluation indexes include peripheral blood lymphocyte immunoassay, improvement of sleep, diet and exercise, progress free survival (PFS) and overall survival (OS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | oxyhydrogen generator (AMS-H-03) | Rated gas output (L) : 3L/min, concentration of hydrogen and the oxygen was 66.6% and 33.3%, respectively. The patients inhale 3 hours each day through a cannula or mask, and persist for long term |
| DEVICE | analogue machine | This machine has the same apperance and gas condition |
Timeline
- Start date
- 2018-06-02
- Primary completion
- 2020-06-20
- Completion
- 2020-08-20
- First posted
- 2019-01-28
- Last updated
- 2020-10-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03818347. Inclusion in this directory is not an endorsement.